Skip to main content
Top
Published in: Head & Neck Oncology 1/2012

Open Access 01-12-2012 | Research

Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro

Authors: Nyla Dil, Abhijit G Banerjee

Published in: Head & Neck Oncology | Issue 1/2012

Login to get access

Abstract

Background

Oral cancer accounts for roughly 3% of cancer cases in the world with about 350,000 newly reported cases annually and a 5-year survival rate of only 50%. Majority of oral cancers are squamous cell carcinomas that originate in the oral mucosal epithelial linings. We have previously shown that in human malignant squamous cells carcinoma (SCC-25) as well as in dysplastic oral keratinocytes (DOK), a small leucine-rich multifunctional proteoglycan decorin is aberrantly expressed and localized in the nucleus where it interacts with nuclear epidermal growth factor receptor (EGFR). Post-transcriptional silencing of nuclear decorin significantly reduced IL-8 and IL8-dependent migration and invasion in these dysplastic and malignant oral epithelia. The objective of this study was to further examine the effects of nuclear decorin silencing on angiogenesis and angiogenesis related mediators in this oral cancer progression cell line model.

Methods

We have used multiplex PCR, western blotting, and in vitro endothelial tube formation assay to study angiogenesis and related pathways in nuclear decorin silenced (stable knockdown) DOK and SCC-25 cells.

Results

Nuclear decorin knockdown resulted in significant down regulation of IL-8 expression, however IL-10, and TGF-β expression was not affected in either DOK or SCC25 cells as measured by multiplex RT PCR. IL-8 receptor CXCR 1 and 2 expression was slightly lower in nuclear decorin silenced cells indicating a contributing mechanism in previously shown reduced IL-8 mediated migration and invasion phenotype in these cells. IL-8 is known to induce Matrix metalloproteinase 9 (MMP9) which not only plays a role in tumour migration and invasion but also induces angiogenic switch. We found MMP9 to be significantly reduced in nuclear decorin silenced dysplastic and malignant oral epithelia. Other potent angiogenic mediators, VEGF189 and ANG-1 were either significantly reduced or completely abrogated in these cells. Angiogenesis as measured by endothelial tube-like formations of HUVEC cells was reduced by almost 50 percent when HUVECs were incubated in the presence of conditioned medium form nuclear decorin silenced dysplastic and malignant cell lines as compared to respective controls.

Conclusions

Together these results indicate that aberrantly expressed nuclear localized decorin strongly influences angiogenic potential of dysplastic and malignant oral epithelial cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ: National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck. 2009, 31: 748-758. 10.1002/hed.21022.CrossRefPubMed Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ: National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck. 2009, 31: 748-758. 10.1002/hed.21022.CrossRefPubMed
2.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics. CA Cancer J Clin. 2008, 58: 71-96. 10.3322/CA.2007.0010.CrossRefPubMed Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics. CA Cancer J Clin. 2008, 58: 71-96. 10.3322/CA.2007.0010.CrossRefPubMed
3.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.CrossRefPubMed
4.
go back to reference de Camargo Cancela M, Voti L, Guerra-Yi M, Chapuis F, Mazuir M, Curado MP: Oral cavity cancer in developed and in developing countries: population-based incidence. Head Neck. 2010, 32: 357-367.PubMed de Camargo Cancela M, Voti L, Guerra-Yi M, Chapuis F, Mazuir M, Curado MP: Oral cavity cancer in developed and in developing countries: population-based incidence. Head Neck. 2010, 32: 357-367.PubMed
5.
go back to reference Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996, 86: 353-364. 10.1016/S0092-8674(00)80108-7.CrossRefPubMed Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996, 86: 353-364. 10.1016/S0092-8674(00)80108-7.CrossRefPubMed
6.
go back to reference Bergers G, Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003, 3: 401-410. 10.1038/nrc1093.CrossRefPubMed Bergers G, Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003, 3: 401-410. 10.1038/nrc1093.CrossRefPubMed
7.
go back to reference Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000, 2: 737-744. 10.1038/35036374.PubMedCentralCrossRefPubMed Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000, 2: 737-744. 10.1038/35036374.PubMedCentralCrossRefPubMed
8.
go back to reference Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989, 161: 851-858. 10.1016/0006-291X(89)92678-8.CrossRefPubMed Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989, 161: 851-858. 10.1016/0006-291X(89)92678-8.CrossRefPubMed
9.
go back to reference Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol. 1991, 5: 1806-1814. 10.1210/mend-5-12-1806.CrossRefPubMed Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol. 1991, 5: 1806-1814. 10.1210/mend-5-12-1806.CrossRefPubMed
10.
go back to reference Charnock-Jones DS, Sharkey AM, Rajput-Williams J, Burch D, Schofield JP, Fountain SA, Boocock CA, Smith SK: Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod. 1993, 48: 1120-1128. 10.1095/biolreprod48.5.1120.CrossRefPubMed Charnock-Jones DS, Sharkey AM, Rajput-Williams J, Burch D, Schofield JP, Fountain SA, Boocock CA, Smith SK: Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod. 1993, 48: 1120-1128. 10.1095/biolreprod48.5.1120.CrossRefPubMed
11.
go back to reference Neufeld G, Cohen T, Gitay-Goren H, Poltorak Z, Tessler S, Sharon R, Gengrinovitch S, Levi BZ: Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev. 1996, 15: 153-158. 10.1007/BF00437467.CrossRefPubMed Neufeld G, Cohen T, Gitay-Goren H, Poltorak Z, Tessler S, Sharon R, Gengrinovitch S, Levi BZ: Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev. 1996, 15: 153-158. 10.1007/BF00437467.CrossRefPubMed
12.
go back to reference Smith BD, Smith GL, Carter D, Sasaki CT, Haffty BG: Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol. 2000, 18: 2046-2052.PubMed Smith BD, Smith GL, Carter D, Sasaki CT, Haffty BG: Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol. 2000, 18: 2046-2052.PubMed
13.
go back to reference Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK: Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev. 2011, 91: 1071-1121. 10.1152/physrev.00038.2010.PubMedCentralCrossRefPubMed Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK: Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev. 2011, 91: 1071-1121. 10.1152/physrev.00038.2010.PubMedCentralCrossRefPubMed
14.
16.
go back to reference Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol. 2000, 18: 217-242. 10.1146/annurev.immunol.18.1.217.CrossRefPubMed Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol. 2000, 18: 217-242. 10.1146/annurev.immunol.18.1.217.CrossRefPubMed
17.
go back to reference Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992, 258: 1798-1801. 10.1126/science.1281554.CrossRefPubMed Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992, 258: 1798-1801. 10.1126/science.1281554.CrossRefPubMed
18.
go back to reference Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Strieter RM: Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med. 1994, 179: 1409-1415. 10.1084/jem.179.5.1409.CrossRefPubMed Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Strieter RM: Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med. 1994, 179: 1409-1415. 10.1084/jem.179.5.1409.CrossRefPubMed
19.
go back to reference Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ: Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun. 1995, 210: 51-57. 10.1006/bbrc.1995.1626.CrossRefPubMed Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ: Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun. 1995, 210: 51-57. 10.1006/bbrc.1995.1626.CrossRefPubMed
20.
go back to reference Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass MC, Taub DT, Iannettoni MD, Whyte RI, Strieter RM: Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med. 1996, 184: 981-992. 10.1084/jem.184.3.981.CrossRefPubMed Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass MC, Taub DT, Iannettoni MD, Whyte RI, Strieter RM: Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med. 1996, 184: 981-992. 10.1084/jem.184.3.981.CrossRefPubMed
21.
go back to reference Perollet C, Han ZC, Savona C, Caen JP, Bikfalvi A: Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood. 1998, 91: 3289-3299.PubMed Perollet C, Han ZC, Savona C, Caen JP, Bikfalvi A: Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood. 1998, 91: 3289-3299.PubMed
22.
go back to reference Jouan V, Canron X, Alemany M, Caen JP, Quentin G, Plouet J, Bikfalvi A: Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood. 1999, 94: 984-993.PubMed Jouan V, Canron X, Alemany M, Caen JP, Quentin G, Plouet J, Bikfalvi A: Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood. 1999, 94: 984-993.PubMed
23.
go back to reference Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, Kunkel SL: Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol. 1995, 57: 752-762.PubMed Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, Kunkel SL: Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol. 1995, 57: 752-762.PubMed
24.
go back to reference Murdoch C, Monk PN, Finn A: Cxc chemokine receptor expression on human endothelial cells. Cytokine. 1999, 11: 704-712. 10.1006/cyto.1998.0465.CrossRefPubMed Murdoch C, Monk PN, Finn A: Cxc chemokine receptor expression on human endothelial cells. Cytokine. 1999, 11: 704-712. 10.1006/cyto.1998.0465.CrossRefPubMed
25.
go back to reference Lingen MW, Polverini PJ, Bouck NP: Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am J Pathol. 1996, 149: 247-258.PubMedCentralPubMed Lingen MW, Polverini PJ, Bouck NP: Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am J Pathol. 1996, 149: 247-258.PubMedCentralPubMed
26.
go back to reference Lalla RV, Goralnick SJ, Tanzer ML, Kreutzer DL: Fibrin induces IL-8 expression from human oral squamous cell carcinoma cells. Oral Oncol. 2001, 37: 234-242. 10.1016/S1368-8375(00)00090-7.CrossRefPubMed Lalla RV, Goralnick SJ, Tanzer ML, Kreutzer DL: Fibrin induces IL-8 expression from human oral squamous cell carcinoma cells. Oral Oncol. 2001, 37: 234-242. 10.1016/S1368-8375(00)00090-7.CrossRefPubMed
27.
go back to reference Banerjee AG, Bhattacharyya I, Lydiatt WM, Vishwanatha JK: Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Cancer Res. 2003, 63: 7769-7776.PubMed Banerjee AG, Bhattacharyya I, Lydiatt WM, Vishwanatha JK: Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Cancer Res. 2003, 63: 7769-7776.PubMed
28.
go back to reference Dil N, Banerjee AG: A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells. Head Neck Oncol. 2011, 3: 44-10.1186/1758-3284-3-44.PubMedCentralCrossRefPubMed Dil N, Banerjee AG: A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells. Head Neck Oncol. 2011, 3: 44-10.1186/1758-3284-3-44.PubMedCentralCrossRefPubMed
29.
go back to reference Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ: Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 1991, 51: 3972-3981.PubMed Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ: Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 1991, 51: 3972-3981.PubMed
30.
go back to reference Hsu S, Borke JL, Lewis JB, Singh B, Aiken AC, Huynh CT, Schuster GS, Caughman GB, Dickinson DP, Smith AK, et al: Transforming growth factor beta 1 dysregulation in a human oral carcinoma tumour progression model. Cell Prolif. 2002, 35: 183-192. 10.1046/j.1365-2184.2002.00237.x.CrossRefPubMed Hsu S, Borke JL, Lewis JB, Singh B, Aiken AC, Huynh CT, Schuster GS, Caughman GB, Dickinson DP, Smith AK, et al: Transforming growth factor beta 1 dysregulation in a human oral carcinoma tumour progression model. Cell Prolif. 2002, 35: 183-192. 10.1046/j.1365-2184.2002.00237.x.CrossRefPubMed
31.
go back to reference Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971, 285: 1182-1186. 10.1056/NEJM197111182852108.CrossRefPubMed Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971, 285: 1182-1186. 10.1056/NEJM197111182852108.CrossRefPubMed
32.
go back to reference Petruzzelli GJ: Tumor angiogenesis. Head Neck. 1996, 18: 283-291. 10.1002/(SICI)1097-0347(199605/06)18:3<283::AID-HED11>3.0.CO;2-C.CrossRefPubMed Petruzzelli GJ: Tumor angiogenesis. Head Neck. 1996, 18: 283-291. 10.1002/(SICI)1097-0347(199605/06)18:3<283::AID-HED11>3.0.CO;2-C.CrossRefPubMed
33.
go back to reference Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 1994, 79: 185-188. 10.1016/0092-8674(94)90187-2.CrossRefPubMed Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 1994, 79: 185-188. 10.1016/0092-8674(94)90187-2.CrossRefPubMed
34.
go back to reference Yang SK, Eckmann L, Panja A, Kagnoff MF: Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology. 1997, 113: 1214-1223. 10.1053/gast.1997.v113.pm9322516.CrossRefPubMed Yang SK, Eckmann L, Panja A, Kagnoff MF: Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology. 1997, 113: 1214-1223. 10.1053/gast.1997.v113.pm9322516.CrossRefPubMed
35.
go back to reference Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP: Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res. 2000, 6: 2104-2119.PubMed Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP: Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res. 2000, 6: 2104-2119.PubMed
36.
go back to reference Richards BL, Eisma RJ, Spiro JD, Lindquist RL, Kreutzer DL: Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am J Surg. 1997, 174: 507-512. 10.1016/S0002-9610(97)00165-7.CrossRefPubMed Richards BL, Eisma RJ, Spiro JD, Lindquist RL, Kreutzer DL: Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am J Surg. 1997, 174: 507-512. 10.1016/S0002-9610(97)00165-7.CrossRefPubMed
37.
go back to reference Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ: Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood. 2000, 96: 34-40.PubMed Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ: Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood. 2000, 96: 34-40.PubMed
38.
go back to reference Li A, Dubey S, Varney ML, Dave BJ, Singh RK: IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol. 2003, 170: 3369-3376.CrossRefPubMed Li A, Dubey S, Varney ML, Dave BJ, Singh RK: IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol. 2003, 170: 3369-3376.CrossRefPubMed
39.
go back to reference Kuwahara I, Lillehoj EP, Lu W, Singh IS, Isohama Y, Miyata T, Kim KC: Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-{kappa}B activation via EGFR transactivation in a lung epithelial cell line. Am J Physiol Lung Cell Mol Physiol. 2006, 291: L407-L416. 10.1152/ajplung.00471.2005.CrossRefPubMed Kuwahara I, Lillehoj EP, Lu W, Singh IS, Isohama Y, Miyata T, Kim KC: Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-{kappa}B activation via EGFR transactivation in a lung epithelial cell line. Am J Physiol Lung Cell Mol Physiol. 2006, 291: L407-L416. 10.1152/ajplung.00471.2005.CrossRefPubMed
40.
go back to reference Roupe KM, Nybo M, Sjobring U, Alberius P, Schmidtchen A, Sorensen OE: Injury is a major inducer of epidermal innate immune responses during wound healing. J Invest Dermatol. 2010, 130: 1167-1177. 10.1038/jid.2009.284.CrossRefPubMed Roupe KM, Nybo M, Sjobring U, Alberius P, Schmidtchen A, Sorensen OE: Injury is a major inducer of epidermal innate immune responses during wound healing. J Invest Dermatol. 2010, 130: 1167-1177. 10.1038/jid.2009.284.CrossRefPubMed
41.
go back to reference McCawley LJ, Matrisian LM: Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today. 2000, 6: 149-156. 10.1016/S1357-4310(00)01686-5.CrossRefPubMed McCawley LJ, Matrisian LM: Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today. 2000, 6: 149-156. 10.1016/S1357-4310(00)01686-5.CrossRefPubMed
42.
go back to reference Fidler IJ, Ellis LM: Chemotherapeutic drugs–more really is not better. Nat Med. 2000, 6: 500-502. 10.1038/74969.CrossRefPubMed Fidler IJ, Ellis LM: Chemotherapeutic drugs–more really is not better. Nat Med. 2000, 6: 500-502. 10.1038/74969.CrossRefPubMed
43.
go back to reference Nor JE, Christensen J, Mooney DJ, Polverini PJ: Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol. 1999, 154: 375-384. 10.1016/S0002-9440(10)65284-4.PubMedCentralCrossRefPubMed Nor JE, Christensen J, Mooney DJ, Polverini PJ: Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol. 1999, 154: 375-384. 10.1016/S0002-9440(10)65284-4.PubMedCentralCrossRefPubMed
44.
go back to reference Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, Korneluk RG, Kerbel RS: Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun. 1999, 264: 781-788. 10.1006/bbrc.1999.1589.CrossRefPubMed Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, Korneluk RG, Kerbel RS: Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun. 1999, 264: 781-788. 10.1006/bbrc.1999.1589.CrossRefPubMed
45.
go back to reference Brindle NP, Saharinen P, Alitalo K: Signaling and functions of angiopoietin-1 in vascular protection. Circ Res. 2006, 98: 1014-1023. 10.1161/01.RES.0000218275.54089.12.PubMedCentralCrossRefPubMed Brindle NP, Saharinen P, Alitalo K: Signaling and functions of angiopoietin-1 in vascular protection. Circ Res. 2006, 98: 1014-1023. 10.1161/01.RES.0000218275.54089.12.PubMedCentralCrossRefPubMed
46.
go back to reference Abdel-Malak NA, Srikant CB, Kristof AS, Magder SA, Di Battista JA, Hussain SN: Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8. Blood. 2008, 111: 4145-4154. 10.1182/blood-2007-08-110338.CrossRefPubMed Abdel-Malak NA, Srikant CB, Kristof AS, Magder SA, Di Battista JA, Hussain SN: Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8. Blood. 2008, 111: 4145-4154. 10.1182/blood-2007-08-110338.CrossRefPubMed
Metadata
Title
Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro
Authors
Nyla Dil
Abhijit G Banerjee
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2012
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-4-11

Other articles of this Issue 1/2012

Head & Neck Oncology 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine